A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America

Journal of Neurosurgery

Volumn 86, Issue 3, 1997, Pages 467-474

  Haley E C , Jr ^a   Kassell, N F ^a   Apperson Hansen, C ^a   Maile, M H ^a   Alves, W M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cerebral aneurysm; cerebral ischemia; cerebral vasospasm; lipid peroxidation; subarachnoid hemorrhage; tirilazad

Indexed keywords

CITRIC ACID; DRUG VEHICLE; NIMODIPINE; PLACEBO; TIRILAZAD;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INJURY SCALE; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORTH AMERICA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 0031028302     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.86.3.0467     Document Type: Article

References (24)